Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Faculty, Medical | 10 | 2022 | 1219 | 1.350 |
Why?
|
| Teaching | 8 | 2018 | 1169 | 1.140 |
Why?
|
| Pulmonary Medicine | 4 | 2015 | 222 | 1.060 |
Why?
|
| Education, Medical, Undergraduate | 6 | 2017 | 1085 | 0.820 |
Why?
|
| Schools, Medical | 4 | 2022 | 876 | 0.600 |
Why?
|
| Solitary Pulmonary Nodule | 2 | 2014 | 276 | 0.590 |
Why?
|
| Education, Medical | 4 | 2018 | 1746 | 0.570 |
Why?
|
| Curriculum | 5 | 2017 | 3782 | 0.550 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2012 | 418 | 0.450 |
Why?
|
| Students, Medical | 5 | 2017 | 1959 | 0.440 |
Why?
|
| Peer Review | 1 | 2016 | 217 | 0.430 |
Why?
|
| Carotid Artery, Common | 1 | 2014 | 172 | 0.420 |
Why?
|
| Zygomycosis | 1 | 2012 | 7 | 0.400 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2014 | 1566 | 0.380 |
Why?
|
| Anesthesia, Local | 1 | 2014 | 276 | 0.370 |
Why?
|
| Intergenerational Relations | 1 | 2012 | 68 | 0.370 |
Why?
|
| Lung Diseases, Fungal | 1 | 2012 | 123 | 0.370 |
Why?
|
| Educational Measurement | 3 | 2017 | 1260 | 0.370 |
Why?
|
| Inservice Training | 1 | 2013 | 375 | 0.360 |
Why?
|
| Career Choice | 2 | 2014 | 769 | 0.350 |
Why?
|
| Risk Management | 1 | 2013 | 559 | 0.330 |
Why?
|
| Aneurysm, Infected | 1 | 2010 | 82 | 0.330 |
Why?
|
| Aortic Valve Stenosis | 2 | 2014 | 2023 | 0.330 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2009 | 42 | 0.320 |
Why?
|
| Self-Assessment | 1 | 2012 | 400 | 0.320 |
Why?
|
| Awareness | 1 | 2013 | 653 | 0.320 |
Why?
|
| Pathology, Clinical | 1 | 2012 | 377 | 0.310 |
Why?
|
| Problem-Based Learning | 1 | 2012 | 360 | 0.300 |
Why?
|
| Clinical Clerkship | 2 | 2012 | 568 | 0.300 |
Why?
|
| Program Evaluation | 2 | 2016 | 2499 | 0.290 |
Why?
|
| Aneurysm, False | 1 | 2010 | 264 | 0.290 |
Why?
|
| Reimbursement Mechanisms | 1 | 2013 | 672 | 0.290 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2014 | 3247 | 0.280 |
Why?
|
| Hospital Costs | 1 | 2013 | 956 | 0.280 |
Why?
|
| Aortic Rupture | 1 | 2010 | 303 | 0.280 |
Why?
|
| Nerve Block | 1 | 2014 | 715 | 0.270 |
Why?
|
| Respiratory Paralysis | 1 | 2007 | 32 | 0.270 |
Why?
|
| Thalidomide | 1 | 2012 | 886 | 0.270 |
Why?
|
| Aortic Aneurysm | 1 | 2010 | 623 | 0.250 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 1870 | 0.240 |
Why?
|
| Medicine | 1 | 2013 | 942 | 0.240 |
Why?
|
| Guideline Adherence | 2 | 2014 | 2243 | 0.220 |
Why?
|
| Aortic Valve | 1 | 2014 | 1968 | 0.220 |
Why?
|
| Staff Development | 3 | 2018 | 230 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2014 | 20659 | 0.210 |
Why?
|
| Population Surveillance | 1 | 2014 | 2590 | 0.210 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2004 | 221 | 0.210 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2012 | 1404 | 0.190 |
Why?
|
| Societies, Medical | 1 | 2014 | 3956 | 0.190 |
Why?
|
| Lung Transplantation | 3 | 2006 | 1311 | 0.180 |
Why?
|
| Bariatric Surgery | 1 | 2011 | 997 | 0.180 |
Why?
|
| Aortography | 2 | 2014 | 414 | 0.170 |
Why?
|
| Warfarin | 1 | 2008 | 1494 | 0.170 |
Why?
|
| Intensive Care Units | 1 | 2013 | 3800 | 0.170 |
Why?
|
| Lung Diseases | 1 | 2009 | 1940 | 0.160 |
Why?
|
| Tai Ji | 2 | 2014 | 289 | 0.160 |
Why?
|
| Cardiac Output | 1 | 2001 | 840 | 0.160 |
Why?
|
| Dyspnea | 1 | 2007 | 1352 | 0.160 |
Why?
|
| Physicians | 2 | 2013 | 4588 | 0.150 |
Why?
|
| Learning | 3 | 2022 | 1755 | 0.150 |
Why?
|
| Decision Support Techniques | 1 | 2008 | 2003 | 0.150 |
Why?
|
| Vascular Resistance | 1 | 2001 | 941 | 0.150 |
Why?
|
| Ambulatory Care | 1 | 2009 | 2778 | 0.150 |
Why?
|
| Clinical Protocols | 2 | 2014 | 1441 | 0.150 |
Why?
|
| Academic Medical Centers | 3 | 2014 | 2780 | 0.140 |
Why?
|
| Pulmonary Embolism | 2 | 2008 | 2598 | 0.140 |
Why?
|
| Emphysema | 2 | 2012 | 234 | 0.140 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 3925 | 0.140 |
Why?
|
| Fatal Outcome | 2 | 2012 | 1831 | 0.130 |
Why?
|
| Spirometry | 2 | 2012 | 929 | 0.130 |
Why?
|
| Group Processes | 1 | 2017 | 224 | 0.130 |
Why?
|
| Respiratory Function Tests | 4 | 2012 | 1693 | 0.120 |
Why?
|
| Foramen Ovale, Patent | 1 | 2018 | 211 | 0.120 |
Why?
|
| Feedback | 2 | 2016 | 796 | 0.110 |
Why?
|
| Humans | 44 | 2022 | 765968 | 0.110 |
Why?
|
| Birt-Hogg-Dube Syndrome | 1 | 2014 | 39 | 0.110 |
Why?
|
| Pneumonectomy | 2 | 2012 | 1128 | 0.110 |
Why?
|
| Sleep Medicine Specialty | 1 | 2014 | 72 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2008 | 4862 | 0.100 |
Why?
|
| Tracheomalacia | 1 | 2013 | 63 | 0.100 |
Why?
|
| Pilot Projects | 4 | 2016 | 8733 | 0.100 |
Why?
|
| Interprofessional Relations | 1 | 2018 | 999 | 0.100 |
Why?
|
| Communication | 2 | 2018 | 3916 | 0.100 |
Why?
|
| Tracheal Diseases | 1 | 2012 | 117 | 0.100 |
Why?
|
| Cardiovascular Agents | 1 | 2018 | 851 | 0.100 |
Why?
|
| Secondary Prevention | 1 | 2018 | 1472 | 0.100 |
Why?
|
| Peer Review, Health Care | 1 | 2012 | 73 | 0.090 |
Why?
|
| Telecommunications | 1 | 2012 | 79 | 0.090 |
Why?
|
| Critical Care | 2 | 2015 | 2712 | 0.090 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2013 | 216 | 0.090 |
Why?
|
| Graft Rejection | 1 | 2004 | 4499 | 0.090 |
Why?
|
| Mind-Body Therapies | 1 | 2014 | 294 | 0.090 |
Why?
|
| Cost Control | 1 | 2013 | 624 | 0.090 |
Why?
|
| Lung Neoplasms | 2 | 2014 | 13451 | 0.090 |
Why?
|
| Oximetry | 1 | 2014 | 459 | 0.090 |
Why?
|
| Pneumothorax | 1 | 2014 | 392 | 0.090 |
Why?
|
| Sepsis | 2 | 2018 | 2606 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2001 | 1604 | 0.090 |
Why?
|
| Bupivacaine | 1 | 2014 | 432 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2014 | 15880 | 0.080 |
Why?
|
| Trachea | 2 | 2013 | 1085 | 0.080 |
Why?
|
| Staphylococcus epidermidis | 1 | 2010 | 121 | 0.080 |
Why?
|
| Pulmonary Ventilation | 1 | 2012 | 377 | 0.080 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2013 | 499 | 0.080 |
Why?
|
| Catheterization, Central Venous | 1 | 2015 | 539 | 0.080 |
Why?
|
| Male | 24 | 2018 | 363698 | 0.080 |
Why?
|
| Tidal Volume | 1 | 2012 | 519 | 0.080 |
Why?
|
| Hospital Departments | 1 | 2009 | 135 | 0.080 |
Why?
|
| Exercise Tolerance | 2 | 2012 | 841 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 13648 | 0.080 |
Why?
|
| Musculoskeletal Physiological Phenomena | 1 | 2009 | 31 | 0.080 |
Why?
|
| Boston | 2 | 2012 | 9338 | 0.080 |
Why?
|
| Incidental Findings | 1 | 2014 | 697 | 0.080 |
Why?
|
| Aged | 16 | 2018 | 171117 | 0.080 |
Why?
|
| Obesity | 1 | 2011 | 13076 | 0.080 |
Why?
|
| Drugs, Generic | 1 | 2013 | 456 | 0.070 |
Why?
|
| Fee-for-Service Plans | 1 | 2013 | 716 | 0.070 |
Why?
|
| Patient Care Planning | 1 | 1993 | 906 | 0.070 |
Why?
|
| Multiple Organ Failure | 1 | 2010 | 390 | 0.070 |
Why?
|
| Bronchial Diseases | 2 | 2006 | 151 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2014 | 1426 | 0.070 |
Why?
|
| Hospitals, Teaching | 1 | 2012 | 1158 | 0.070 |
Why?
|
| Anesthetics, Local | 1 | 2014 | 1015 | 0.070 |
Why?
|
| Exercise Test | 2 | 2012 | 2180 | 0.070 |
Why?
|
| Phrenic Nerve | 1 | 2007 | 81 | 0.070 |
Why?
|
| Social Environment | 1 | 2012 | 1011 | 0.070 |
Why?
|
| Blood Transfusion | 1 | 2013 | 1297 | 0.070 |
Why?
|
| Musculoskeletal System | 1 | 2009 | 187 | 0.070 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 866 | 0.070 |
Why?
|
| Radiography, Interventional | 1 | 2014 | 1129 | 0.070 |
Why?
|
| Pleural Effusion | 1 | 2009 | 346 | 0.060 |
Why?
|
| Phosphates | 1 | 1990 | 763 | 0.060 |
Why?
|
| Oxygen | 2 | 2012 | 4241 | 0.060 |
Why?
|
| Hematoma | 1 | 2010 | 766 | 0.060 |
Why?
|
| Kidney Calculi | 1 | 1990 | 457 | 0.060 |
Why?
|
| Echocardiography | 1 | 2018 | 5045 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 2108 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2014 | 12976 | 0.060 |
Why?
|
| Heart Valve Prosthesis | 1 | 2014 | 1466 | 0.060 |
Why?
|
| Piperidines | 1 | 2014 | 1664 | 0.060 |
Why?
|
| Documentation | 1 | 2012 | 916 | 0.060 |
Why?
|
| Bronchiectasis | 1 | 2006 | 141 | 0.060 |
Why?
|
| Income | 1 | 2013 | 1874 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2012 | 24282 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2009 | 1628 | 0.060 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2010 | 1093 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 2796 | 0.060 |
Why?
|
| Cysts | 1 | 2009 | 684 | 0.060 |
Why?
|
| Female | 19 | 2018 | 396112 | 0.060 |
Why?
|
| Medical Records | 1 | 2009 | 1409 | 0.060 |
Why?
|
| Perioperative Care | 1 | 2012 | 1055 | 0.060 |
Why?
|
| Rare Diseases | 1 | 2009 | 635 | 0.050 |
Why?
|
| Drainage | 1 | 2009 | 1179 | 0.050 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2013 | 1188 | 0.050 |
Why?
|
| Hemangioma, Capillary | 1 | 2003 | 64 | 0.050 |
Why?
|
| Health Care Costs | 2 | 2013 | 3242 | 0.050 |
Why?
|
| Middle Aged | 14 | 2018 | 223009 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2009 | 1315 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 20124 | 0.050 |
Why?
|
| Posture | 1 | 2007 | 954 | 0.050 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2002 | 115 | 0.050 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 1292 | 0.050 |
Why?
|
| Bronchi | 1 | 2006 | 843 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2013 | 2517 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 4520 | 0.050 |
Why?
|
| Living Donors | 1 | 2006 | 645 | 0.050 |
Why?
|
| Recurrence | 2 | 2018 | 8501 | 0.050 |
Why?
|
| Life Expectancy | 1 | 2008 | 1247 | 0.050 |
Why?
|
| Doxycycline | 1 | 2003 | 349 | 0.050 |
Why?
|
| Radiographic Image Enhancement | 1 | 2006 | 872 | 0.050 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 59489 | 0.050 |
Why?
|
| Massachusetts | 2 | 2012 | 8875 | 0.050 |
Why?
|
| Osteoporosis | 1 | 2011 | 1582 | 0.050 |
Why?
|
| Retrospective Studies | 6 | 2018 | 81514 | 0.050 |
Why?
|
| Internship and Residency | 2 | 2013 | 5946 | 0.050 |
Why?
|
| Health Expenditures | 1 | 2013 | 2387 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 2334 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2008 | 1078 | 0.040 |
Why?
|
| Data Collection | 1 | 2009 | 3318 | 0.040 |
Why?
|
| Self Report | 1 | 2012 | 3770 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 1993 | 3278 | 0.040 |
Why?
|
| Orthopedics | 1 | 2009 | 900 | 0.040 |
Why?
|
| Sarcoidosis | 1 | 2005 | 532 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 14751 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2006 | 1224 | 0.040 |
Why?
|
| United States | 3 | 2017 | 72903 | 0.040 |
Why?
|
| Age Factors | 2 | 2012 | 18380 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2018 | 65188 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2012 | 12437 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2014 | 3835 | 0.040 |
Why?
|
| Vasodilation | 1 | 2001 | 970 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15398 | 0.040 |
Why?
|
| Septal Occluder Device | 1 | 2018 | 127 | 0.030 |
Why?
|
| Pulmonary Emphysema | 1 | 2002 | 683 | 0.030 |
Why?
|
| Calcium | 1 | 1990 | 5767 | 0.030 |
Why?
|
| Lung | 2 | 2006 | 10033 | 0.030 |
Why?
|
| Mentors | 1 | 2022 | 671 | 0.030 |
Why?
|
| Stroke | 1 | 2018 | 9747 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 11022 | 0.030 |
Why?
|
| Adult | 11 | 2018 | 223044 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2013 | 5370 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2004 | 2395 | 0.030 |
Why?
|
| Kidney | 1 | 1990 | 7066 | 0.030 |
Why?
|
| Breathing Exercises | 1 | 2014 | 59 | 0.030 |
Why?
|
| Acute Disease | 1 | 2004 | 7232 | 0.030 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1995 | 176 | 0.030 |
Why?
|
| Time Factors | 2 | 2018 | 40065 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2007 | 5993 | 0.030 |
Why?
|
| Forced Expiratory Volume | 2 | 2010 | 1828 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2003 | 2056 | 0.030 |
Why?
|
| Health Status | 1 | 2006 | 4080 | 0.030 |
Why?
|
| Manikins | 1 | 2015 | 251 | 0.030 |
Why?
|
| Peer Group | 1 | 2018 | 701 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2001 | 1935 | 0.030 |
Why?
|
| Professional Autonomy | 1 | 2013 | 172 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 18071 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2011 | 39193 | 0.020 |
Why?
|
| Models, Educational | 1 | 2015 | 376 | 0.020 |
Why?
|
| Mental Health | 1 | 2006 | 3278 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 7478 | 0.020 |
Why?
|
| Professional Practice | 1 | 1993 | 313 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2001 | 4184 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2015 | 677 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2018 | 2105 | 0.020 |
Why?
|
| Sleep | 1 | 2007 | 4813 | 0.020 |
Why?
|
| Sex Factors | 1 | 2004 | 10603 | 0.020 |
Why?
|
| Survival Rate | 1 | 2004 | 12795 | 0.020 |
Why?
|
| Absorption | 1 | 1990 | 242 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2012 | 1600 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 30198 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 1995 | 995 | 0.020 |
Why?
|
| Nephrons | 1 | 1990 | 165 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2022 | 54802 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2009 | 15747 | 0.020 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2006 | 93 | 0.020 |
Why?
|
| Pedigree | 1 | 2014 | 4526 | 0.020 |
Why?
|
| Total Lung Capacity | 1 | 2006 | 148 | 0.020 |
Why?
|
| Fatigue | 1 | 2013 | 1549 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 1995 | 3160 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 1135 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2001 | 8532 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 2615 | 0.020 |
Why?
|
| Algorithms | 1 | 2006 | 14071 | 0.020 |
Why?
|
| Walking | 1 | 2012 | 1198 | 0.020 |
Why?
|
| Organizational Innovation | 1 | 2008 | 541 | 0.010 |
Why?
|
| Patient Participation | 1 | 1993 | 1455 | 0.010 |
Why?
|
| Exhalation | 1 | 2005 | 184 | 0.010 |
Why?
|
| Physical Endurance | 1 | 2006 | 368 | 0.010 |
Why?
|
| Vital Capacity | 1 | 2006 | 995 | 0.010 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2006 | 373 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 1990 | 1789 | 0.010 |
Why?
|
| Risk Factors | 3 | 2018 | 74840 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 8067 | 0.010 |
Why?
|
| Emotions | 1 | 2014 | 2763 | 0.010 |
Why?
|
| Isotopes | 1 | 2002 | 124 | 0.010 |
Why?
|
| Consensus | 1 | 2012 | 3202 | 0.010 |
Why?
|
| Helium | 1 | 2002 | 119 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2003 | 594 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 10383 | 0.010 |
Why?
|
| Endothelium | 1 | 2003 | 767 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2006 | 2352 | 0.010 |
Why?
|
| Quality of Life | 2 | 2014 | 13462 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2006 | 2739 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 3432 | 0.010 |
Why?
|
| Adolescent | 2 | 2004 | 88835 | 0.010 |
Why?
|
| Patient-Centered Care | 1 | 2008 | 1458 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 15842 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2013 | 13039 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22223 | 0.010 |
Why?
|
| Infant | 2 | 1995 | 36386 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 36532 | 0.010 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1995 | 96 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2006 | 3475 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 4058 | 0.010 |
Why?
|
| Phagocytes | 1 | 1995 | 292 | 0.010 |
Why?
|
| Diet | 1 | 1990 | 8086 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1995 | 841 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14652 | 0.010 |
Why?
|
| Safety | 1 | 1995 | 1157 | 0.010 |
Why?
|
| Growth Disorders | 1 | 1995 | 633 | 0.010 |
Why?
|
| Neutropenia | 1 | 1995 | 893 | 0.010 |
Why?
|
| Fever | 1 | 1995 | 1603 | 0.000 |
Why?
|
| Prognosis | 1 | 2006 | 29922 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 6493 | 0.000 |
Why?
|
| Incidence | 1 | 1995 | 21480 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1995 | 42500 | 0.000 |
Why?
|
| Child | 1 | 1995 | 80564 | 0.000 |
Why?
|
Concepts
(287)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(50)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_